PVLA
Palvella Therapeutics
PVLA
PVLA
105 hedge funds and large institutions have $199M invested in Palvella Therapeutics in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 115 → 105 (-10)
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $363K
Holders
105
Holding in Top 10
3
Calls
–
Puts
$363K
Top Buyers
| 1 | +$3.56M | |
| 2 | +$3.48M | |
| 3 | +$1.69M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.42M |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$1.4M |
Top Sellers
| 1 | -$3.83M | |
| 2 | -$2.4M | |
| 3 | -$1.3M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$932K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$884K |